Search details
1.
The IARC Perspective on Cervical Cancer Screening.
N Engl J Med
; 386(6): 607, 2022 02 10.
Article
in English
| MEDLINE | ID: mdl-35139284
2.
Researchers should no longer delay implementation of Pap screening in low and middle income countries pending research into novel screening approaches.
Infect Agent Cancer
; 19(1): 18, 2024 Apr 26.
Article
in English
| MEDLINE | ID: mdl-38671517
3.
Correspondence regarding Castle., Human papillomavirus screening for low and middle-income countries.
Prev Med
; 105: 357-358, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-28780060
4.
Human papillomavirus screening for low and middle-income countries.
Prev Med
; 100: 296, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28583662
5.
Cervical cancer mortality in India.
Lancet
; 383(9931): 1804, 2014 May 24.
Article
in English
| MEDLINE | ID: mdl-24856023
6.
Self-collection of vaginal specimens for HPV testing.
Lancet
; 379(9826): 1587-8; author reply 1588-9, 2012 Apr 28.
Article
in English
| MEDLINE | ID: mdl-22541576
7.
Unethical US Government-Funded Cervical Screening Study in India: US Freedom of Information Act Disclosures.
J Healthc Sci Humanit
; 8(2): 57-78, 2018.
Article
in English
| MEDLINE | ID: mdl-36818400
8.
WHO should adjust its global strategy for cervical cancer prevention.
BMJ Glob Health
; 8(6)2023 06.
Article
in English
| MEDLINE | ID: mdl-37308263
9.
HPV screening for cervical cancer in rural India.
N Engl J Med
; 361(3): 304; author reply 306, 2009 Jul 16.
Article
in English
| MEDLINE | ID: mdl-19605838
10.
Cervical cancer prevention for all the world's women: genuine promise resides in skilled quality management rather than novel screening approaches.
Diagn Cytopathol
; 35(3): 187-91, 2007 Mar.
Article
in English
| MEDLINE | ID: mdl-17304532
11.
Unethical randomised controlled trial of cervical screening in India: US Freedom of Information Act disclosures.
BMJ Glob Health
; 2(2): e000177, 2017.
Article
in English
| MEDLINE | ID: mdl-28589014
12.
HPV vaccination: waiting for evidence of effectiveness.
Lancet
; 375(9715): 639-40, 2010 Feb 20.
Article
in English
| MEDLINE | ID: mdl-20171401
13.
Human papillomavirus vaccine.
N Engl J Med
; 357(11): 1155; author reply 1155-6, 2007 Sep 13.
Article
in English
| MEDLINE | ID: mdl-17874469
14.
Coming to terms with Vietnam: the Viet/American Cervical Cancer Prevention Project.
Diagn Cytopathol
; 33(5): 344-51, 2005 Nov.
Article
in English
| MEDLINE | ID: mdl-16240403
15.
Cost-effectiveness of cervical-cancer screening in developing countries.
N Engl J Med
; 354(14): 1535-6; author reply 1535-6, 2006 Apr 06.
Article
in English
| MEDLINE | ID: mdl-16598056
16.
Papanicolaou screening in developing countries: an idea whose time has come.
Am J Clin Pathol
; 121(3): 315-20, 2004 Mar.
Article
in English
| MEDLINE | ID: mdl-15023034
17.
Crossing the quality chasm: a requirement for successful cervical cancer prevention in developing countries.
Clin Lab Med
; 24(4): 945-63, 2004 Dec.
Article
in English
| MEDLINE | ID: mdl-15555750
18.
US-funded measurements of cervical cancer death rates in India: scientific and ethical concerns.
Indian J Med Ethics
; 11(3): 167-75, 2014.
Article
in English
| MEDLINE | ID: mdl-25101547
19.
Response by Eric Suba to Sankaranarayanan et al.
Indian J Med Ethics
; 11(3): 178-80, 2014.
Article
in English
| MEDLINE | ID: mdl-25101551
20.
Lessons learned from successful Papanicolaou cytology cervical cancer prevention in the Socialist Republic of Vietnam.
Diagn Cytopathol
; 40(4): 355-66, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-21394935